Skip to main content
. 2020 Jul 22;10:1081. doi: 10.3389/fonc.2020.01081

Table 3.

Autoantibodies positive for candidate tumor-associated antigens in colorectal cancer patients negative for CEA.

CEA ALDH1B1 aAb UQCRC1 aAb CTAG1 aAb CENPF aAb
CEA (+) TAAb (+) 37 (42.5%) 24 (64.9%) 23 (62.2%) 21 (56.8%) 24 (64.9%)
TAAb (–) 13 (35.1%) 14 (37.8%) 16 (43.2%) 13 (35.1%)
CEA (–) TAAb (+) 50 (57.5%) 31 (62.0%) 30 (60.0%) 35 (70.0%) 25 (50.0%)
TAAb (–) 19 (38.0%) 20 (40.0%) 15 (30.0%) 25 (50%)

aAb, autoantibody; CEA, carcinoembryonic antigen.